Abstract
Kaixinsan powder (KXS), a classic prescription of traditional Chinese Medicine (TCM), is widely used in the treatment of depression, but its mechanism remains unclear. The network pharmacology method was used to constructe the “herb-component-target” network, and elucidated KXS potential mechanisms of action in the treatment of depression. Moreover, molecular docking was applied to valid the important interactions between the ingredients and the target protein. The “herb-component-target” network indicated that the ingredients of Girinimbin, Gomisin B and Asarone, and the protein targets of ESR, AR and NR3C1 mostly contribute to the antidepressant effect of KXS. KEGG pathway analysis highlighted the most significant pathways associated with depression treatment, including neuroactive ligand-receptor interaction pathway, serotonergic synapse pathway, PI3K-Akt signaling pathway and MAPK signaling pathway. Go enrichment analysis indicated that the mechanism of KXS in treating depression was involved in the biological process of GPCR signal transduction, hormone metabolism and nerve cell apoptosis. Moreover, molecular docking results showed that Polygalaxanthone III, Girinimbine and Pachymic acid performed greater binding ability with key antidepressant target 5-HTR. In conclusion, this study preliminarily revealed key active components in KXS, including Gomisin B, Asarone, Ginsenoside Rg1, Polygalaxanthone III and Pachymic acid, could interact with multiple targets (5-HTR, DR, ADRA, AR, ESR, NR3C1) and modulate the activation of multiple pathways (Neuroactive ligand -receptor interaction pathway, serotonergic synapse pathway, PI3K-Akt signaling pathway and MAPK signaling pathway).
Similar content being viewed by others
Data availability
Data will be made available on reasonable request.
Abbreviations
- KXS:
-
Kaixinsan powder
- TCM:
-
Traditional Chinese Medicine
- SSRIs:
-
Selective serotonin reuptake inhibitors
- TCMSP:
-
Traditional Chinese Medicine System Pharmacology Database
- OB:
-
Oral bioavailability
- DL:
-
Drug-like
- PPI:
-
Protein-protein interaction
- GPCR:
-
G protein coupled receptor
References
Amberger JS, Bocchini CA, Schiettecatte F, Scott AF, Hamosh A (2015) OMIM.org: online Mendelian Inheritance in Man (OMIM®), an online catalog of human genes and genetic disorders. Nucleic Acids Res 43(D1):D789–D798. https://doi.org/10.1093/nar/gku1205
Araki R, Hiraki Y, Nishida S, Inatomi Y, Yabe T (2016) Gomisin N ameliorates lipopolysaccharide-induced depressive-like behaviors by attenuating inflammation in the hypothalamic paraventricular nucleus and central nucleus of the amygdala in mice. J Pharmacol Sci 132(2):138–144. https://doi.org/10.1016/j.jphs.2016.09.004
Burley SK, Berman HM, Kleywegt GJ, Markley JL, Nakamura H, Velankar S (2017) Protein Data Bank (PDB): the single global macromolecular structure archive. Methods Mol Biol 1607:627–641. https://doi.org/10.1007/978-1-4939-7000-1_26
Cao C, Xiao J, Liu M, Ge Z, Huang R, Qi M, Zhu H, Zhu Y, Duan J-A (2018) Active components, derived from Kai-xin-san, a herbal formula, increase the expressions of neurotrophic factor NGF and BDNF on mouse astrocyte primary cultures via cAMP-dependent signaling pathway. J Ethnopharmacol 224:554–562. https://doi.org/10.1016/j.jep.2018.06.007
Cao LH, Qiao JY, Huang HY, Fang XY, Zhang R, Miao MS, Li XM (2019) PI3K-AKT signaling activation and icariin: the potential effects on the perimenopausal depression-like rat model. Mol 24(20):3700. https://doi.org/10.3390/molecules24203700
Caviedes A, Lafourcade C, Soto C, Wyneken U (2017) BDNF/NF-kB signaling in the neurobiology of depression. Curr Pharm Des 23(21):3154–3163. https://doi.org/10.2174/1381612823666170111141915
Chellian R, Pandy V, Mohamed Z (2016) Biphasic effects of α-Asarone on immobility in the tail suspension test: evidence for the involvement of the noradrenergic and serotonergic systems in its antidepressant-like activity. Front Pharmacol 7:72. https://doi.org/10.3389/fphar.2016.00072
Chellian R, Pandy V, Mohamed Z (2018) Alpha-asarone attenuates depression-like behavior in nicotine-withdrawn mice: Evidence for the modulation of hippocampal pCREB levels during nicotine-withdrawal. Eur J Pharmacol 818:10–16. https://doi.org/10.1016/j.ejphar.2017.10.025
Chen X, Ji ZL, Chen YZ (2002) TTD: Therapeutic Target Database. Nucleic Acids Res 30(1):412–415. https://doi.org/10.1093/nar/30.1.412
Chu H, Lu S, Kong L, Han Y, Han J, Liu Z, Zhang A, Wang X (2016) Dynamic analysis of the effects of pharmacodynamic constituents of Kai Xin San on Alzheimer’s disease rats based on chinmedomics. Modernization of Traditional Chinese Medicine and Materia Medica-World Science and Technology 18(10):1653–1669. https://doi.org/10.11842/wst.2016.10.006
Daina A, Michielin O, Zoete V (2019) Swiss Target Prediction: updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res 47(W1):W357–W364. https://doi.org/10.1093/nar/gkz382
David DJ, Gardier AM (2016a) The pharmacological basis of the serotonin system: application to antidepressant response. Encephale 42(3):255–263. https://doi.org/10.1016/j.encep.2016.03.012
David DJ, Gourion D (2016b) Antidepressant and tolerance: determinants and management of major side effects. Encephale 42(6):553–561. https://doi.org/10.1016/j.encep.2016.05.006
Dean J, Keshavan M (2017) The neurobiology of depression: an integrated view. Asian J Psychiatr 27:101–111. https://doi.org/10.1016/j.ajp.2017.01.025
Dong XZ, Wang DX, Lu YP, Yuan S, Liu P, Hu Y (2017) Antidepressant effects of Kai-Xin-San in fluoxetine-resistant depression rats. Braz J Med Biol Res 50(10):e6161. https://doi.org/10.1590/1414-431X20176161
Dong H, Cong W, Guo X, Wang Y, Tong S, Li Q, Li C (2019) β-asarone relieves chronic unpredictable mild stress induced depression by regulating the extracellular signal-regulated kinase signaling pathway. Exp Ther Med 18(5):3767–3774. https://doi.org/10.3892/etm.2019.8018
Du X, Pang TY, Mo C, Renoir T, Wright DJ, Hannan AJ (2015) The influence of the HPG axis on stress response and depressive-like behavior in a transgenic mouse model of Huntington’s disease. Exp Neurol 263:63–71. https://doi.org/10.1016/j.expneurol.2014.09.009
Guo LT, Wang SQ, Su J, Xu LX, Ji ZY, Zhang R-Y, Zhao QW, Ma ZQ, Deng XY, Ma SP (2019) Baicalin ameliorates neuroinflammation-induced depressive-like behavior through inhibition of toll-like receptor 4 expression via the PI3K/AKT/FoxO1 pathway. J Neuroinflammation 16(1):1–21. https://doi.org/10.1186/s12974-019-1474-8
Kiraly DD, Horn SR, Van Dam NT, Costi S, Schwartz J, Kim-Schulze S, Patel M, Hodes GE, Russo SJ, Merad M, Iosifescu DV, Charney DS, Murrough JW (2017) Altered peripheral immune profiles in treatment-resistant depression: response to ketamine and prediction of treatment outcome. Transl Psychiatry 7(3):e1065. https://doi.org/10.1038/tp.2017.31
Li J, Gao W, Zhao Z, Li Y, Yang L, Wei W, Ren F, Li Y, Yu Y, Duan W, Li J, Dai B, Guo R (2022) Ginsenoside Rg1 reduced microglial activation and mitochondrial dysfunction to alleviate depression-like behaviour via the GAS5/EZH2/SOCS3/NRF2 axis. Mol Neurobiol 59(5):2855–2873. https://doi.org/10.1007/s12035-022-02740-7
Lopes CT, Franz M, Kazi F, Donaldson SL, Morris Q, Bader GD (2010) Cytoscape web: an interactive web-based network browser. Bioinformatics 26(18):2347–2348. https://doi.org/10.1093/bioinformatics/btq430
Mattingly CJ, Colby GT, Forrest JN, Boyer JL (2003) The Comparative Toxicogenomics Database (CTD). Environ Health Perspect 111(6):793–795. https://doi.org/10.1289/ehp.6028
Ménard C, Hodes GE, Russo SJ (2016) Pathogenesis of depression: insights from human and rodent studies. Neuroscience 321:138–162. https://doi.org/10.1016/j.neuroscience.2015.05.053
Mohan S, Hobani YH, Shaheen E, Abou-Elhamd AS, Abdelhaleem A, Alhazmi HA, Abdelwahab SI (2020) Girinimbine from curry leaves promotes gastro protection against ethanol induced peptic ulcers and improves healing via regulation of anti-inflammatory and antioxidant mechanisms. Food Funct 11(4):3493–3505. https://doi.org/10.1039/d0fo00053a
Mou Z, Huang Q, Chu SF, Zhang MJ, Hu JF, Chen NH, Zhang JT (2017) Antidepressive effects of ginsenoside Rg1 via regulation of HPA and HPG axis. Biomed Pharmacother 92:962–971. https://doi.org/10.1016/j.biopha.2017.05.119
Naoi M, Maruyama W, Shamoto-Nagai M (2018) Type A monoamine oxidase and serotonin are coordinately involved in depressive disorders: from neurotransmitter imbalance to impaired neurogenesis. J Neural Transm 125(1):53–66. https://doi.org/10.1007/s00702-017-1709-8
Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM (2002) Neurobiology of depression. Neuron 34(1):13–25. https://doi.org/10.1016/s0896-6273(02)00653-0
Newberg AB, Amsterdam JD, Wintering N, Justine S (2012) Low brain serotonin transporter binding in major depressive disorder. Psychiat Res Neuroim 202:161–167. https://doi.org/10.1016/j.pscychresns.2011.12.015
Pahwa P, Singh T, Goel RK (2022) Anticonvulsant effect of asparagus racemosus willd. in a mouse model of catamenial epilepsy. Neurochem Res 47(2):422–433. https://doi.org/10.1007/s11064-021-03455-2
Perez-Caballero L, Torres-Sanchez S, Bravo L, Mico JA, Berrocoso E (2014) Fluoxetine: a case history of its discovery and preclinical development. Expert Opin Drug Discov 9(5):567–578. https://doi.org/10.1517/17460441.2014.907790
Proulx É, Suri D, Heximer SP, Vaidya VA, Lambe EK (2014) Early stress prevents the potentiation of muscarinic excitation by calcium release in adult prefrontal cortex. Biol Psychiatry 76(4):315–323. https://doi.org/10.1016/j.biopsych.2013.10.017
Rebhan M, Chalifa-Caspi V, Prilusky J, Lancet D (1997) GeneCards: integrating information about genes, proteins and diseases. Trends Genet 13(4):163. https://doi.org/10.1016/s0168-9525(97)01103-7
Ru J, Li P, Wang J, Zhou W, Li B, Huang C, Li P, Guo Z, Tao W, Yang Y, Xu X, Li Y, Wang Y, Yang L (2014) TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform 6:13. https://doi.org/10.1186/1758-2946-6-13
Ruhé HG, Mason NS, Schene AH (2007) Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies. Mol Psychiatry 12(4):331–359. https://doi.org/10.1038/sj.mp.4001949
Si Y, Song Z, Sun X, Wang JH (2018) microRNA and mRNA profiles in nucleus accumbens underlying depression versus resilience in response to chronic stress. Am J Med Genet B Neuropsychiatr Genet 177(6):563–579. https://doi.org/10.1002/ajmg.b.32651
Singh T, Goel RK (2016) Adjuvant indoleamine 2,3-dioxygenase enzyme inhibition for comprehensive management of epilepsy and comorbid depression. Eur J Pharmacol 784:111–120. https://doi.org/10.1016/j.ejphar.2016.05.019
Singh T, Goel RK (2021) Epilepsy associated depression: an update on current scenario, suggested mechanisms, and opportunities. Neurochem Res 46(6):1305–1321. https://doi.org/10.1007/s11064-021-03274-5
Singh T, Kaur T, Goel RK (2017a) Adjuvant quercetin therapy for combined treatment of epilepsy and comorbid depression. Neurochem Int 104:27–33. https://doi.org/10.1016/j.neuint.2016.12.023
Singh T, Kaur T, Goel RK (2017b) Ferulic acid supplementation for management of depression in epilepsy. Neurochem Res 42(10):2940–2948. https://doi.org/10.1007/s11064-017-2325-6
Tiwari P, Fanibunda SE, Kapri D, Vasaya S, Pati S, Vaidya VA (2021) GPCR signaling: role in mediating the effects of early adversity in psychiatric disorders. FEBS J 288(8):2602–2621. https://doi.org/10.1111/febs.15738
Tu H-H, Liu P, Mu L, Liao H-B, Xie T-T, Ma L-H, Liu Y-M (2008) Study on antidepressant components of sucrose ester from Polygala tenuifolia. Zhongguo Zhong Yao Za Zhi 33(11):1278–1280. https://pubmed.ncbi.nlm.nih.gov/18831206/. Accessed 1 June 2008
Vermeersch H, T’sjoen G, Kaufman JM, Houtte MV (2013) ESR1 polymorphisms, daily hassles, anger expression, and depressive symptoms in adolescent boys and girls. Horm Behav 63(3):447–453. https://doi.org/10.1016/j.yhbeh.2012.11.017
Wang H, Yang Y, Yang S, Ren S, Feng J, Liu Y, Chen H, Chen N (2022) Ginsenoside Rg1 ameliorates neuroinflammation via suppression of connexin43 ubiquitination to attenuate depression. Front Pharmacol 12:709019. https://doi.org/10.3389/fphar.2021.709019
Xiao YG,·Wu HB,·Chen JS, Li X,·Qiu ZK (2022) Exploring the potential antidepressant mechanisms of pinellia by using the network pharmacology and molecular docking. Metab Brain Dis. Online ahead of print. https://doi.org/10.1007/s11011-022-00930-9
Xu X, Zhang W, Huang C, Li Y, Yu H, Wang Y, Duan J, Ling Y (2012) A novel chemometric method for the prediction of human oral bioavailability. Int J Mol Sci 13(6):6964–6982. https://doi.org/10.3390/ijms13066964
Yan L, Hu Q, Mak MSH, Lou J, Xu SL, Bi CWC, Zhu Y, Wang H, Dong TTX, Tsim KWK (2016) A Chinese herbal decoction, reformulated from Kai-Xin-San, relieves the depression-like symptoms in stressed rats and induces neurogenesis in cultured neurons. Sci Rep 6:30014. https://doi.org/10.1038/srep30014
Yan T, Nian T, Liao Z, Xiao F, Wu B, Bi K, He B, Jia Y (2020) Antidepressant effects of a polysaccharide from okra (Abelmoschus esculentus (L) Moench) by anti-inflammation and rebalancing the gut microbiota. Int J Biol Macromol 144:427–440. https://doi.org/10.1016/j.ijbiomac.2019.12.138
Yu G, Wang W, Wang X, Xu M, Zhang L, Ding L, Guo R, Shi Y (2018) Network pharmacology-based strategy to investigate pharmacological mechanisms of Zuojinwan for treatment of gastritis. BMC Complement Altern Med 18(1):292. https://doi.org/10.1186/s12906-018-2356-9
Zhai Y, Liu B, Wu L, Zou M, Mei X, Mo X (2022) Pachymic acid prevents neuronal cell damage induced by hypoxia/reoxygenation via miR-155/NRF2/HO-1 axis. Acta Neurobiol Exp 82(2):197–206. https://doi.org/10.55782/ane-2022-018
Zhang X, Li Q, Lv C, Xu H, Liu X, Sui Z, Bi K (2015) Characterization of multiple constituents in Kai-Xin-San prescription and rat plasma after oral administration by liquid chromatography with quadrupole time-of-flight tandem mass spectrometry. J Sep Sci 38(12):2068–2075. https://doi.org/10.1002/jssc.201500123
Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, Benner C, Chanda SK (2019) Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun 10(1):1523. https://doi.org/10.1038/s41467-019-09234-6
Zhu Y, Duan X, Huang F, Cheng X, Zhang L, Liu P, Shulan S, Duan J-A, Dong TT-X, Tsim KW-K (2016) Kai-Xin-San, a traditional Chinese medicine formula, induces neuronal differentiation of cultured PC12 cells: Modulating neurotransmitter regulation enzymes and potentiating NGF inducing neurite outgrowth. J Ethnopharmacol 193:272–282. https://doi.org/10.1016/j.jep.2016.08.013
Acknowledgements
This work was financially supported by Scientific Research Project of Health Commission of Hubei Province (WJ2019F034) and Project of Wuhan Health and Family Planning Commission (WX17D37).
Author information
Authors and Affiliations
Contributions
Y-SK and H-CG provided the concept and designed the study. D-LJ and Z-XN conducted the main experiments and wrote the paper. S-YF participated in data analysis. L-SS and J-HZ supported the research design, reviewed the proposal, and participated in the revision of the manuscript.
Corresponding authors
Ethics declarations
Consent to publish
All the authors listed have approved the manuscript that is enclosed.
Conflicts of interest
Declarations of interest: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Du, LJ., Zhang, XN., Li, SS. et al. Network pharmacological investigation into the mechanism of Kaixinsan powder for the treatment of depression. Metab Brain Dis 37, 2903–2914 (2022). https://doi.org/10.1007/s11011-022-01067-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-022-01067-5